Targeting the Microtubular Network as a New Antimyeloma Strategy
Rentian Feng(National Institute for Occupational Safety and Health), Suzanne Lentzsch(Columbia University Irving Medical Center)
Cited by 28
Related Papers
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493
Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid
|Journal of Biological Chemistry|2005|388
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
|The Lancet Oncology|2021|266
Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease
|Journal of Clinical Investigation|2016|73